Recurrent Urinary Tract Infection Vaccine Referral

Recurrent Urinary Tract Infection Vaccine Referral

The Uromune™ MV140 vaccine experimental Recurrent Urinary Tract Infection (rUTI) inactivated oral spray vaccine is approved for use by adults in various countries. Uromune initially became available in Spain and is now available in 26 countries, including England, Europe, and Mexico.

Please complete the form below to receive a rUTI vaccine referral. Please note that as of 2025, Uromune is not available in the United States. This means that to become immunized against rUTIs, you would need to travel internationally.

This self-administered rUTI vaccine contains four whole-cell inactivated bacteria suspended in water. Uromine vaccination has been found in research studies to reduce the number of UTIs and increase the time to the next UTI from 48 days to 275 days.

Travel Vaccination Services 2025

While traveling abroad in 2025, various health agencies recommend travel vaccines when visiting disease-endemic areas.